NRP1 and breast cancer: Finally, this report emphasized the importance of NRP-1 targeting with a new direction focusing on ECM proteins in treating metastatic breast cancer, which might aid not only in reducing the ability of the cells to metastasize but also in making them more susceptible to treatment.